Last update Dec. 4, 2020
Very Low Risk
We do not have alternatives for E1105 (muramidase) since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
E1105 (muramidase) is also known as Lysozyme Hydrochloride. Here it is a list of alternative known names::
E1105 (muramidase) in other languages or writings:
E1105 (muramidase) belongs to these groups or families:
Main tradenames from several countries containing E1105 (muramidase) in its composition:
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
A mucopolysaccharidase present in various body fluids (saliva, breastmilk, tears) with antibacterial, antiviral and antifungal action (Giuffrida 2018, Lönnerdal 2003, Mata 1971).
It is a protein made up of approximately 130 amino acids.
Since the last update we have not found any published data in relation to breastfeeding.
Its high molecular weight makes its excretion in breastmilk highly unlikely.
Due to its protein nature, it is inactivated in the gastrointestinal tract, not being absorbed (practically nil oral bioavailability), which hinders or prevents the transfer to infant plasma from breastmilk, except in premature cases and the immediate neonatal period, when there may be increased intestinal permeability.